support@mellalta.com   +1 (304) 306-0723

Big Pharma Companies bet on Actym Therapeutics microbial-based STACT platform for Oncology Treatment

Big Companies like Boehringer Ingelheim Venture Fund (BIVF) and Panacea Venture, with participation from Illumina Ventures, Korea Investment Partners (KIP), and JLo Ventures bets on Designer GMO bacteria of Actym Therapeutics. Actym completed a $34 […]

Read More

Get In Touch

Let's keep the conversation going